301
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Liraglutide for type 2 diabetes mellitus

, &
Pages 951-959 | Published online: 12 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ozge Telci Caklili, Mustafa Cesur, Dimitri P Mikhailidis & Manfredi Rizzo. (2023) Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview. Diabetes, Metabolic Syndrome and Obesity 16, pages 1767-1774.
Read now
Chen-Hsiu Lin, Li Shao, Yu-Mei Zhang, Yu-Ju Tu, Yuzhen Zhang, Brian Tomlinson, Paul Chan & Zhongmin Liu. (2020) An evaluation of liraglutide including its efficacy and safety for the treatment of obesity. Expert Opinion on Pharmacotherapy 21:3, pages 275-285.
Read now

Articles from other publishers (2)

Kenneth E. Carlson, Thomas J. McMurry & Stephen W. HuntIIIIII. (2012) Pepducins: lipopeptide allosteric modulators of GPCR signaling. Drug Discovery Today: Technologies 9:1, pages e33-e39.
Crossref
Jorge Plutzky. (2011) The Incretin Axis in Cardiovascular Disease. Circulation 124:21, pages 2285-2289.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.